Bronte Capital Management’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-154,878
Closed -$596K 36
2023
Q2
$596K Sell
154,878
-2,577
-2% -$9.46K 0.06% 32
2023
Q1
$476K Sell
157,455
-1,950
-1% -$6.74K 0.06% 30
2022
Q4
$327K Sell
159,405
-4,142
-3% -$12.6K 0.04% 27
2022
Q3
$566K Hold
163,547
0.07% 28
2022
Q2
$689K Buy
163,547
+323
+0.2% +$763 0.08% 32
2022
Q1
$496K Buy
163,224
+6,008
+4% +$23K 0.07% 31
2021
Q4
$731K Sell
157,216
-2,246
-1% -$15.5K 0.09% 29
2021
Q3
$1.23M Hold
159,462
0.18% 27
2021
Q2
$1.37M Buy
+159,462
New +$1.41M 0.21% 21

Other funds holding DBTX